Risk factors associated with hepatitis C virus infection in Taiwanese government employees

Epidemiology and Infection

Volumn 126, Issue 2, 2001, Pages 291-299

  Chang, H C ^a   Yu, M W ^a   Lu, C F ^b   Chiu, Y H ^a   Chen, C J ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ACADEMIC ACHIEVEMENT; ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; BLOOD GROUP O; BLOOD TRANSFUSION; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DRINKING BEHAVIOR; EMPLOYEE; ETHNOLOGY; EXPOSURE; GOVERNMENT; HEPATITIS C; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS; SEROLOGY; SURGERY; TAIWAN; VIRUS TRANSMISSION;

ADULT; AGED; BLOOD TRANSFUSION; EDUCATIONAL STATUS; GOVERNMENT; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RISK FACTORS; SMOKING; TAIWAN;

EID: 0035018053     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268801005362     Document Type: Article

References (35)

1. Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 1993; 34 suppl: S13-6.
2. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994; 17: 71-91.
3. Darby SC, Ewart DW, Giangrande PLF, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997; 350: 1425-31.
4. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-6.
5. Alric L, Fort M, Izopet J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterol 1997; 113: 1675-81.
6. Tibbs C, Donaldson P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV-infection in Northern European Caucasoids. Hepatol 1996; 24: 1342-5.
7. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991; 51: 5621-5.
8. Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; ii: 294-7.
9. Nishiguchi S, Kuroki T, Yabusako T, et al. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatol 1991; 14: 985-9.
10. Zignego AL, Foschi M, Laffi G, et al. 'Inapparent' hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatol 1994; 19: 577-82.
11. Oshita M, Hayashi N, Kasahara A, et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatol 1994; 20: 1115-20.
12. Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol 1998; 83: 148-56.
13. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771-4.
14. Yu MW, Chiu YH, Chiang YC, et al. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol 1999; 149: 621-9.
15. Contreras M, Barbara JAJ, Anderson CC, et al. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology. Lancet 1991; 337: 753-7.
16. Mortimer PP, Cohen BJ, Litton PA, et al. Hepatitic C virus antibody. Lancet 1989; ii: 798.
17. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 1990; 335: 754-7.
18. Lok ASF, Ma OCK, Chan TM, et al. Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera. Hepatol 1991; 14: 756-62.
19. Esteban JI, López-Talavera JC, Genescà J, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115: 443-9.
20. Kleinman S, Alter H, Busch M, et al. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992; 32: 805-13.
21. Kiyosawa K, Sodeyama T, Tanaka E, et al. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med 1991; 115: 367-9.
22. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995; 345: 289-91.
23. Chen DS, Kuo GC, Sung JL, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990; 162: 817-22.
24. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 1999; 59: 290-6.
25. Tsai SL, Chen YM, Chen MH, et al. Hepatitis C virus variants circumventing cytotoxic T-lymphocyte activity as a mechanism of chronicity. Gastroenterol 1998; 115: 954-66.
26. Alter HJ, Purcel RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494-500.
27. Farci P, Alter HJ, Wong D, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991; 325: 98-104.
28. Pontisso P, Ruvoletto MG, Fattovich G, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterol 1993; 105: 1529-33.
29. Shih CM, Lo SJ, Miyamura T, Chen SY, Wu Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993; 67: 5823-32.
30. Sheen IS, Liaw YF, Chu CM, Pao CC. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearence during chronic hepatitis B virus infection. J Infect Dis 1992; 165: 831-4.
31. Glass RI, Holmgren J, Haley CE, et al. Predisposition for cholera of individuals with O blood group: possible evolutionary significance. Am J Epidemiol 1985; 121: 791-6.
32. Borén T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262: 1892-5.
33. Weiner AJ, Brauer MJ, Rosenblatt J, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelop and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842-8.
34. Weiner AJ, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89: 3468-72.
35. Sakuma I, Enomoto N, Kurosaki M, Marumo F, Sato C. Selection of hepatitis C virus quasispecies during interferon treatment. Arch Virol 1996; 141: 1921-32.